PubMed:22061999 / 877-1194 JSONTXT

{"project":"uniprot-human","denotations":[{"id":"T3","span":{"begin":198,"end":210},"obj":"http://www.uniprot.org/uniprot/Q6I9R6"}],"text":"Importantly, the enzymatic properties including kinetic parameters, half-maximal inhibitory concentration of isofagomine and thermal stability of the cgl-derived GCase were comparable with those of imiglucerase, a commercially available recombinant human GCase used for enzyme replacement therapy in Gaucher patients."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T9","span":{"begin":125,"end":132},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/68933"}],"text":"Importantly, the enzymatic properties including kinetic parameters, half-maximal inhibitory concentration of isofagomine and thermal stability of the cgl-derived GCase were comparable with those of imiglucerase, a commercially available recombinant human GCase used for enzyme replacement therapy in Gaucher patients."}

{"project":"EDAM-topics","denotations":[{"id":"T14","span":{"begin":249,"end":254},"obj":"http://edamontology.org/topic_2815"}],"text":"Importantly, the enzymatic properties including kinetic parameters, half-maximal inhibitory concentration of isofagomine and thermal stability of the cgl-derived GCase were comparable with those of imiglucerase, a commercially available recombinant human GCase used for enzyme replacement therapy in Gaucher patients."}

{"project":"EDAM-DFO","denotations":[{"id":"T7","span":{"begin":56,"end":66},"obj":"http://edamontology.org/data_2527"},{"id":"T8","span":{"begin":92,"end":105},"obj":"http://edamontology.org/data_2140"}],"text":"Importantly, the enzymatic properties including kinetic parameters, half-maximal inhibitory concentration of isofagomine and thermal stability of the cgl-derived GCase were comparable with those of imiglucerase, a commercially available recombinant human GCase used for enzyme replacement therapy in Gaucher patients."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":317},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":317},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":317},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Importantly, the enzymatic properties including kinetic parameters, half-maximal inhibitory concentration of isofagomine and thermal stability of the cgl-derived GCase were comparable with those of imiglucerase, a commercially available recombinant human GCase used for enzyme replacement therapy in Gaucher patients."}

{"project":"NCBITAXON","denotations":[{"id":"T6","span":{"begin":249,"end":254},"obj":"OrganismTaxon"}],"attributes":[{"id":"A6","pred":"db_id","subj":"T6","obj":"9606"}],"text":"Importantly, the enzymatic properties including kinetic parameters, half-maximal inhibitory concentration of isofagomine and thermal stability of the cgl-derived GCase were comparable with those of imiglucerase, a commercially available recombinant human GCase used for enzyme replacement therapy in Gaucher patients."}